Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.

Krauze, Andra V; Mackey, Megan; Rowe, Lindsay; Chang, Michal G; Holdford, Diane J; Cooley, Theresa; Shih, Joanna; Tofilon, Philip J; Camphausen, Kevin

Krauze, Andra V; Mackey, Megan; Rowe, Lindsay; Chang, Michal G; Holdford, Diane J; Cooley, Theresa; Shih, Joanna; Tofilon, Philip J; Camphausen, Kevin.

Afiliación

Krauze AV; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Mackey M; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Rowe L; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Chang MG; Massey Cancer Center Virginia Commonwealth University, VA.
Holdford DJ; Massey Cancer Center Virginia Commonwealth University, VA.
Cooley T; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Shih J; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Tofilon PJ; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.
Camphausen K; Radiation Oncology Branch, National Cancer Institute/NIH, Center Drive, CRC, Bethesda, MD.

Neurooncol Pract ; 5(4): 246-250, 2018 Nov.

Article en En | MEDLINE | ID: mdl-30402263

Palabras clave

Glioblastoma; Late effects; Valproic Acid; radiation sensitizer; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Diagnostic_studies Idioma: En Revista: Neurooncol Pract Año: 2018 Tipo del documento: Article País de afiliación: Moldova

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google